Evotec SE (EVO)
3.00
+0.10
(+3.45%)
USD |
NASDAQ |
Dec 10, 16:00
2.99
-0.01
(-0.33%)
After-Hours: 20:00
Evotec EPS Diluted (Quarterly): -0.1417 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 1.079 |
| InflaRx NV | -0.2115 |
| BioNTech SE | -0.1395 |
| Immatics NV | -0.4859 |
| CureVac NV | 1.414 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -50.35M |
| Revenue (Quarterly) | 191.51M |
| Total Expenses (Quarterly) | 241.86M |
| Enterprise Value | 1.357B |
| Gross Profit Margin (Quarterly) | -0.04% |
| Profit Margin (Quarterly) | -26.29% |
| Earnings Yield | -16.56% |
| Normalized Earnings Yield | -15.60 |